Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Study procedures

From: Neurocognitive impact of different irradiation modalities for patients with grade I-II skull base meningioma: a prospective multi-arm cohort study (CANCER COG)

 

Screening before inclusion

Baseline assessment (within 6 weeks before radiotherapy start)

During radiotherapy period (7 weeks) for 3 cohorts:

- Cohort IMRT

- Cohort SRT

- Cohort PRT

End of radiotherapy

AFTER THE END of radiotherapy

6 and 12 months

Yearly up to 10 years

Study explanation and signed informed consent

before any study procedures

     

Patients

Standard physical and neurological examination (Nano-scale)

 

Weekly during radiotherapy

 

Cognitive assessment (by a trained neuropsychologist):

 - Executive functions

 - Episodic memory

 - Working memory

 - Short-term memory

 - Attention/Information processing speed

 - Prospective memory (Mem-Pro Clinic)

 

  

(at 3, 5, 7 and 10 years only)

Brain MRI (standard follow-up):3DT1w, Diffusion (b = 0 and b = 1000 s.mm-2, 30 directions), Perfusion (Dynamic Susceptibility Contrast, DSC-MRI), 3DT1 Gadolinium, 3D Fluid Attenuated Inversion Recovery (FLAIR), Angiographic “time of flight” sequence (TOF)

 

  

Cognitive complaints, anxiety and depression assessment

Fact-Cog

- HADS

MFI

 

  

Quality-of-life assessment

- EORTC QLQC30 + BN20

 

  

Evaluation of the socio-professional

reintegration

 

  

At the discretion of the investigator:

Endocrinological, ophthalmological and

audiometric evaluations

 

  

(12 months only)

 

OPTIONAL

Blood sample banking

 

 

Participants free of brain disease

 
 

Baseline assessment

(within 6 weeks before radiotherapy start)

6 and 12 months

Yearly up to 10 years

 

Cognitive assessment (by a trained neuropsychologist):

 - MoCA

 - Executive functions

 - Episodic memory

 - Working memory

 - Short-term memory

 - Attention/Information processing speed

 - Prospective memory (Mem-Pro Clinic)

(at 3, 5, 7 and 10 years only)

 

Cognitive complaints, anxiety and depression assessment

Fact-Cog

 - HADS

 - MFI

 

Quality-of-life assessment

 - EORTC QLQC30